These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15187578

  • 1. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane.
    Sukhotina IA, Zvartau EE, Danysz W, Bespalov AY.
    Behav Pharmacol; 2004 May; 15(3):207-14. PubMed ID: 15187578
    [Abstract] [Full Text] [Related]

  • 2. Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.
    Malyshkin AA, Medvedev IO, Danysz W, Bespalov AY.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):80-5. PubMed ID: 16109402
    [Abstract] [Full Text] [Related]

  • 3. Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice.
    Sukhotina IA, Bespalov AY.
    Psychopharmacology (Berl); 2000 May 05; 149(4):345-50. PubMed ID: 10867961
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane.
    Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM.
    Pharmacol Biochem Behav; 2006 Oct 05; 85(2):298-306. PubMed ID: 17045636
    [Abstract] [Full Text] [Related]

  • 5. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
    Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM.
    J Pharmacol Exp Ther; 1993 Sep 05; 266(3):1563-72. PubMed ID: 8371158
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.
    Kos T, Legutko B, Danysz W, Samoriski G, Popik P.
    J Pharmacol Exp Ther; 2006 Sep 05; 318(3):1128-36. PubMed ID: 16740621
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test.
    Berrino L, Oliva P, Massimo F, Aurilio C, Maione S, Grella A, Rossi F.
    Eur J Pain; 2003 Sep 05; 7(2):131-7. PubMed ID: 12600794
    [Abstract] [Full Text] [Related]

  • 8. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W, Kozela E, Parsons CG, Sladek M, Bauer T, Popik P.
    Neuropharmacology; 2005 Mar 05; 48(3):360-71. PubMed ID: 15721168
    [Abstract] [Full Text] [Related]

  • 9. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure.
    Hölter SM, Danysz W, Spanagel R.
    J Pharmacol Exp Ther; 2000 Feb 05; 292(2):545-52. PubMed ID: 10640291
    [Abstract] [Full Text] [Related]

  • 10. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice.
    Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY.
    Eur Neuropsychopharmacol; 2005 Mar 05; 15(2):219-25. PubMed ID: 15695068
    [Abstract] [Full Text] [Related]

  • 11. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodríguez-Arias M, Miñarro J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep 05; 28(6):1035-43. PubMed ID: 15380865
    [Abstract] [Full Text] [Related]

  • 12. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO, Malyshkin AA, Belozertseva IV, Sukhotina IA, Sevostianova NY, Aliev K, Zvartau EE, Parsons CG, Danysz W, Bespalov AY.
    Neuropharmacology; 2004 Aug 05; 47(2):175-83. PubMed ID: 15223296
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.
    Plazas PV, Savino J, Kracun S, Gomez-Casati ME, Katz E, Parsons CG, Millar NS, Elgoyhen AB.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):11-9. PubMed ID: 17466293
    [Abstract] [Full Text] [Related]

  • 14. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
    Hewlett P, Smith A.
    Hum Psychopharmacol; 2007 Aug 02; 22(6):339-50. PubMed ID: 17514640
    [Abstract] [Full Text] [Related]

  • 15. Effects of the non-competitive NMDA receptor antagonist memantine on the volitional consumption of ethanol by alcohol-preferring rats.
    Malpass GE, Williams HL, McMillen BA.
    Basic Clin Pharmacol Toxicol; 2010 May 02; 106(5):435-44. PubMed ID: 20210793
    [Abstract] [Full Text] [Related]

  • 16. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
    Morè L, Gravius A, Nagel J, Valastro B, Greco S, Danysz W.
    Behav Pharmacol; 2008 Oct 02; 19(7):724-34. PubMed ID: 18797249
    [Abstract] [Full Text] [Related]

  • 17. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF.
    J Pharmacol Exp Ther; 2007 May 02; 321(2):564-72. PubMed ID: 17267580
    [Abstract] [Full Text] [Related]

  • 18. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
    Mares P, Mikulecká A.
    Epilepsy Behav; 2009 Jan 02; 14(1):32-9. PubMed ID: 18786655
    [Abstract] [Full Text] [Related]

  • 19. Withdrawal-like behavior in planarians is dependent on drug exposure duration.
    Sacavage S, Patel H, Zielinski M, Acker J, Phillips AG, Raffa RB, Rawls SM.
    Neurosci Lett; 2008 Jul 04; 439(1):84-8. PubMed ID: 18511196
    [Abstract] [Full Text] [Related]

  • 20. Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice.
    Molinaro G, Battaglia G, Riozzi B, Di Menna L, Rampello L, Bruno V, Nicoletti F.
    Brain Res; 2009 Apr 10; 1265():75-9. PubMed ID: 19236854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.